Seres Therapeutics, Inc. (MCRB)
USD 0.86
(-2.31%)
USD 0.86
(-2.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -117.35 Million | -228.81 Million | 6.68 Million | -93.61 Million | -76.52 Million | -62.85 Million |
| Net Income | -113.72 Million | -250.15 Million | -65.57 Million | -89.12 Million | -70.27 Million | -98.94 Million |
| Depreciation & Amortization | 15.11 Million | 6.62 Million | 5.94 Million | 6.57 Million | 7.6 Million | 7.86 Million |
| Deferred income taxes | -114.22 Million | - | 2.52 Million | - | 103 Thousand | - |
| Stock-based compensation | 34.1 Million | 25.48 Million | 20.22 Million | 8.82 Million | 8.34 Million | 16.64 Million |
| Change in working capital | -58.97 Million | -18.39 Million | 41.53 Million | -23.19 Million | -24.62 Million | 11.79 Million |
| Other non-cash items | 120.36 Million | 7.62 Million | 2.04 Million | 3.31 Million | 2.33 Million | -214 Thousand |
| Investing Cash Flow | 10.58 Million | 82.42 Million | 64.08 Million | -158.89 Million | -30.51 Million | 112.31 Million |
| Investments in PPE | -7.97 Million | -9.82 Million | -9.56 Million | -591 Thousand | -1 Million | -1.93 Million |
| Acquisitions | -18.55 Million | -92.24 Million | -73.65 Million | 19.9 Million | 29.51 Million | - |
| Investment purchases | -4.42 Million | -48.22 Million | -95.97 Million | -218.28 Million | -46.42 Million | -21.83 Million |
| Sales/Maturities of investments | 22.98 Million | 140.47 Million | 169.62 Million | 59.98 Million | 16.9 Million | 136.08 Million |
| Other Investing Activities | 18.55 Million | 92.24 Million | 73.65 Million | -19.9 Million | -29.51 Million | 114.25 Million |
| Financing Cash Flow | 71.7 Million | 129.6 Million | 1.17 Million | 303.42 Million | 86.23 Million | 268 Thousand |
| Debt repayment | -50.51 Million | -1.9 Million | -948 Thousand | -19.9 Million | -25 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -197 Thousand |
| Common Stock Issuance | 21.18 Million | 101.16 Million | 827 Thousand | 303.42 Million | 61.21 Million | 61 Thousand |
| Other Financing Activities | 101.03 Million | 30.34 Million | 1.29 Million | 303.42 Million | 50.01 Million | 404 Thousand |
| Accounts receivables | -8.67 Million | - | 9.38 Million | -7.6 Million | -1.78 Million | - |
| Accounts payables | -11.57 Million | 2.2 Million | 9.36 Million | -1.15 Million | -1.46 Million | -353 Thousand |
| Inventory | -29.64 Million | - | 27.13 Million | -2.87 Million | -3.86 Million | - |
| Other working capital | -9.07 Million | -20.59 Million | -4.35 Million | -11.56 Million | -17.52 Million | 12.15 Million |
| Cash at beginning of period | 163.03 Million | 188 Million | 116.04 Million | 65.12 Million | 85.93 Million | 36.2 Million |
| Cash at end of period | 127.96 Million | 171.21 Million | 188 Million | 116.04 Million | 65.12 Million | 85.93 Million |
| Capital Expenditure | -7.97 Million | -9.82 Million | -9.56 Million | -591 Thousand | -1 Million | -1.93 Million |
| Effect of forex changes on cash | 2000.00 | -1000.00 | -1000.00 | - | - | - |
| Net cash flow / Change in cash | -35.06 Million | -16.78 Million | 71.95 Million | 50.92 Million | -20.8 Million | 49.73 Million |
| Free Cash Flow | -125.32 Million | -238.63 Million | -2.87 Million | -94.2 Million | -77.52 Million | -64.79 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -32.86 Million | -40.13 Million | -113.72 Million | -41.24 Million | -47.85 Million | 46.55 Million |
| Depreciation & Amortization | 1.42 Million | 1.55 Million | 15.11 Million | 4.05 Million | 1.68 Million | 1.52 Million |
| Deferred income taxes | - | - | -114.22 Million | -21.17 Million | 21.36 Million | 1.44 Million |
| Stock-based compensation | 5.53 Million | 6.48 Million | 34.1 Million | 5.08 Million | 8.67 Million | 13.49 Million |
| Change in working capital | -16.63 Million | -9.15 Million | -58.97 Million | -15.38 Million | -22.78 Million | -1.46 Million |
| Other non-cash items | 33.73 Million | 25.08 Million | 120.36 Million | 21.16 Million | -20.34 Million | 4.43 Million |
| Investing Cash Flow | 1.3 Million | -62 Thousand | 10.58 Million | -877 Thousand | -1.79 Million | 10.51 Million |
| Investments in PPE | -99 Thousand | -62 Thousand | -7.97 Million | -877 Thousand | -1.79 Million | -1.23 Million |
| Acquisitions | - | - | -18.55 Million | 6.8 Million | - | - |
| Investment purchases | - | - | -4.42 Million | - | - | - |
| Sales/Maturities of investments | 1.4 Million | - | 22.98 Million | - | - | 11.75 Million |
| Other Investing Activities | 1.4 Million | - | 18.55 Million | -6.8 Million | - | 11.75 Million |
| Financing Cash Flow | - | 18.76 Million | 71.7 Million | 6.42 Million | 1.44 Million | 58.17 Million |
| Debt repayment | - | - | -50.51 Million | -52.86 Million | - | -52.86 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 18.76 Million | 21.18 Million | 6.42 Million | 1.44 Million | 7.49 Million |
| Other Financing Activities | - | 18.76 Million | 101.03 Million | 6.42 Million | 1.44 Million | 103.54 Million |
| Accounts receivables | -11.18 Million | 1.25 Million | -8.67 Million | 8.18 Million | -16.85 Million | -2.24 Million |
| Accounts payables | -410 Thousand | 1.59 Million | -11.57 Million | -5.03 Million | -3.44 Million | 714 Thousand |
| Inventory | -11.02 Million | -12.32 Million | -29.64 Million | -11.12 Million | -13.18 Million | -1.27 Million |
| Other working capital | 5.98 Million | 323 Thousand | -9.07 Million | -7.41 Million | 10.7 Million | 1.34 Million |
| Cash at beginning of period | 111.18 Million | 127.96 Million | 163.03 Million | 169.91 Million | 237.7 Million | 103.02 Million |
| Cash at end of period | 71.23 Million | 111.18 Million | 127.96 Million | 127.96 Million | 178.09 Million | 237.7 Million |
| Capital Expenditure | -99 Thousand | -62 Thousand | -7.97 Million | -877 Thousand | -1.79 Million | -1.23 Million |
| Effect of forex changes on cash | - | - | 2000.00 | 132.53 Million | 1000.00 | -132.53 Million |
| Net cash flow / Change in cash | -39.95 Million | -16.78 Million | -35.06 Million | -41.94 Million | -59.6 Million | 134.67 Million |
| Free Cash Flow | -39.91 Million | -35.29 Million | -125.32 Million | -48.37 Million | -61.05 Million | 64.75 Million |
0KSX
603777
PAGP
MBNKP
MBLV
0JUZ